Assessing Multiple Medication Use With Probabilities of Benefits and Harms
Datos Bibliográficos
| ID | 12797691 |
|---|---|
| Autores | Terrence E Murphy (0000-0002-9687-8998, Yale School of Medicine,, autor de correspondencia), Joseph V Agostini (Yale School of Medicine and VA Connecticut Healthcare System), Peter H van Ness (Yale School of Medicine), Peter Peduzzi (0000-0002-7634-6804, Yale School of Medicine and VA Connecticut Healthcare System), Mary E Tinetti (0000-0003-0940-9702, Yale School of Medicine), Heather Allore (0000-0001-7685-8175, Yale University), Heather G Allore (Yale School of Medicine) |
| Año | 2008 |
| Volumen | 20 |
| Número | 6 |
| Páginas | 694-709 |
| Fecha de publicación | 2008-07-15 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Journal of Aging and Health (JOURNAL) |
| Identificadores de la revista | ISSN: 1552-6887 • E-ISSN: 0898-2643 |
| Editorial | SAGE Publishing (PUBLISHER • US) |
| DOI | 10.1177/0898264308321006 |
| PMID | 18625759 |
| PMCID | PMC3477770 |
| OpenAlex | W2154844428 |
| Idioma | EN |
| Citas recibidas | 2 |
| Referencias citadas | 28 |
The framework proposed provides a simple method for considering the trade-offs involved in prescribing multiple medications. It can be adapted to include additional parameters representing severity of condition, prioritization of outcomes, patient preferences, dosages, and medication interactions. Inconsistent reporting in the medical literature of data about benefits and harms of medications, dosages, and interactions constitutes its primary limitation
Actuarial science · Business · Context (archaeology · Dose · Economics · Machine learning · Management science · Prioritization · Risk analysis (engineering · Value (mathematics · Yield (engineering · Computer Science · Health Systems, Economic Evaluations, Quality of Life · Medication Adherence and Compliance · Medicine · Pharmaceutical Practices and Patient Outcomes · Pharmacology
| Obras citantes distintas | 2 |
|---|---|
| Citas por año | 0,33 |
| Intervalo de citas | 2020 - 2021 (2) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 2 |